Evan Kurtz

Stock Analyst at BMO Capital

(0.49)
# 4,198
Out of 5,126 analysts
22
Total ratings
33.33%
Success rate
-18.36%
Average return

Stocks Rated by Evan Kurtz

Regeneron Pharmaceuticals
Mar 14, 2023
Maintains: Outperform
Price Target: $1,001$1,025
Current: $785.51
Upside: +30.49%
Warrior Met Coal
Oct 2, 2018
Maintains: Equal-Weight
Price Target: $27$29
Current: $89.05
Upside: -67.43%
Steel Dynamics
Aug 27, 2018
Upgrades: Overweight
Price Target: $50$52
Current: $202.39
Upside: -74.31%
Constellium SE
Aug 1, 2018
Maintains: Overweight
Price Target: $15$16
Current: $24.74
Upside: -35.33%
Nucor
Apr 17, 2018
Maintains: Equal-Weight
Price Target: $68$73
Current: $192.84
Upside: -62.14%